Skip to content

Clear Secure YOU Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

HTF
Heartflow, Inc. Common StockHTFL
$15.41M-25.5%
KEE
Keel Infrastructure Corp. Common StockKEEL
$2.19M-50.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$7.96M-63.4%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$6.19M-79.2%
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$1.09M+76.6%
Kulicke & Soffa Industries logo
Kulicke & Soffa IndustriesKLIC
$7M-11.5%

Other financials

Income statement

See full
Revenue$253.0M+19.7%
Operating income$62.0M+65.8%
Net income$38.8M+52.7%
EPS (diluted)$0.38+46.2%

Balance sheet

See full
Cash & equivalents$173.5M+91.4%
Total debt$111.3M-6.9%
Total equity$185.3M+58.8%
Total assets$1.4B+28.0%

Cash flow

See full
Operating cash flow$190.4M+93.6%
CapEx$4.9M-31.2%
Free cash flow$185.5M+103%

Valuation

See full
Market cap$5.31B+91.7%

Profitability

See full
Operating margin22.4%+5.3pp
Net margin13%-9.0pp
FCF margin39.9%+3.0pp

Returns & leverage

See full
Return on equity81.2%-43.6pp
Debt / equity0.6×-0.4×
Current ratio+0.2×

Where this comes from

Reported directly by Clear Secure in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: Clear Secure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clear Secure's indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clear Secure's indefinite-lived research and development assets?
Clear Secure (YOU) reported indefinite-lived research and development assets of $310K in Q1 2026.
What is the long-term trend for Clear Secure's indefinite-lived research and development assets?
Over 3 years (2022 to 2025), Clear Secure's indefinite-lived research and development assets has grown at a 0.0% compound annual growth rate (CAGR), from $310K to $310K.